Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Amortizatization of Intangibles: 2019-2024

Historic Amortizatization of Intangibles for Praxis Precision Medicines (PRAX) over the last 6 years, with Dec 2024 value amounting to $5.0 million.

  • Praxis Precision Medicines' Amortizatization of Intangibles fell 64.84% to $705,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year increase of 12.32%. This contributed to the annual value of $5.0 million for FY2024, which is 498.57% up from last year.
  • Latest data reveals that Praxis Precision Medicines reported Amortizatization of Intangibles of $5.0 million as of FY2024, which was up 498.57% from $837,000 recorded in FY2023.
  • In the past 5 years, Praxis Precision Medicines' Amortizatization of Intangibles ranged from a high of $5.0 million in FY2024 and a low of -$2.1 million during FY2021.
  • Over the past 3 years, Praxis Precision Medicines' median Amortizatization of Intangibles value was $837,000 (recorded in 2023), while the average stood at $1.6 million.
  • In the last 5 years, Praxis Precision Medicines' Amortizatization of Intangibles plummeted by 399.86% in 2021 and then soared by 498.57% in 2024.
  • Praxis Precision Medicines' Amortizatization of Intangibles (Yearly) stood at $696,000 in 2020, then slumped by 399.86% to -$2.1 million in 2021, then skyrocketed by 51.94% to -$1.0 million in 2022, then surged by 183.45% to $837,000 in 2023, then skyrocketed by 498.57% to $5.0 million in 2024.